SUBSCRIBE
SUBSCRIBE
News   Business

Proteome Sciences PLC H1 Pretax Loss Narrows; Sees Licensing for TMT by Year-End

October 2, 2007 | 
1 min read

LONDON (Thomson Financial) - Proteome Sciences PLC posted a narrower first half pretax loss and higher revenues and said it is “well set” to provide strong and sustainable revenue stream.

Earnings Europe
MORE ON THIS TOPIC
Funding
Nuvig Ropes in $161M Series B From Big Pharma Players for Autoimmune Indications
December 5, 2024
 · 
1 min read
 · 
Kate Goodwin
Handshake gesture contemporary collage art. Celebrating success, congratulating for financial and business partnership, job contract deal, mutual friendship and respect. Abstract illustration isolated.
Alzheimer’s disease
GSK Strikes Third Agreement This Week, Leans Further Into Neuro
December 5, 2024
 · 
2 min read
 · 
Tristan Manalac
Facade of Novo Nordisk's office in Fremont, California
Manufacturing
Novo Continues Manufacturing Spending Spree With $400M Denmark Expansion, $200M Plant Purchase
December 5, 2024
 · 
2 min read
 · 
Tristan Manalac
Business
Previous Investment Patterns Set to Repeat in 2025
December 5, 2024
 · 
1 min read
 · 
Lori Ellis